What's The BUZZ?

Market News, Products, Services, and Trends

Amneal Pharmaceuticals News & Announcements

Website

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) is an integrated specialty pharmaceutical company powered by a robust U.S. generics business and a growing branded business. Together, our team is working to build one of the most dynamic pharmaceutical companies in our rapidly changing industry.

Amneal Launches GLP-1 Agonist Exenatide Injection 
Press Releases
Author

Amneal Launches GLP-1 Agonist Exenatide Injection 

May 29, 2025
Amneal Launches BORUZU™, First Ready-to-Use Bortezomib Injection for Multiple Myeloma and Mantle Cell Lymphoma
Press Releases
Author

Amneal Launches BORUZU™, First Ready-to-Use Bortezomib Injection for Multiple Myeloma and Mantle Cell Lymphoma

April 3, 2025
Amneal Launches Mesalamine and Receives U.S. FDA Approval for Lenalidomide
Press Releases
Author

Amneal Launches Mesalamine and Receives U.S. FDA Approval for Lenalidomide

February 21, 2025
Amneal Receives U.S. FDA Approval for Memantine/Donepezil Extended-Release Capsules and Everolimus Tablets for Oral Suspension, and Tentative U.S. FDA Approval for Rifaximin
Press Releases
Author

Amneal Receives U.S. FDA Approval for Memantine/Donepezil Extended-Release Capsules and Everolimus Tablets for Oral Suspension, and Tentative U.S. FDA Approval for Rifaximin

January 29, 2025
Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist
Press Releases
Author

Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist

January 10, 2025
Ready-to-Use Products from Amneal Allow You to Focus on What Matters Most | Amneal 
Product Awareness
Author

Ready-to-Use Products from Amneal Allow You to Focus on What Matters Most | Amneal 

January 6, 2025
Amneal Pharmaceuticals is Named a 2025 Pharmacy500 Company!
Announcements
Author

Amneal Pharmaceuticals is Named a 2025 Pharmacy500 Company!

January 1, 2025
Ready-to-Use Products from Amneal Allow You to Focus on What Matters Most | Amneal [VIDEO]
Product Awareness
Author

Ready-to-Use Products from Amneal Allow You to Focus on What Matters Most | Amneal [VIDEO]

December 20, 2024
Amneal Receives U.S. FDA Approval for Propofol Injectable Emulsion Single Dose Vials
Press Releases
Author

Amneal Receives U.S. FDA Approval for Propofol Injectable Emulsion Single Dose Vials

August 21, 2024
Must See Booths: NACDS Total Store Expo 2024
Must-See Exhibits & Booths
Author

Must See Booths: NACDS Total Store Expo 2024

August 16, 2024
Amneal Receives U.S. FDA Approval for IPX203 for Treatment of Parkinson’s Disease to Be Launched as CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules
Press Releases
Author

Amneal Receives U.S. FDA Approval for IPX203 for Treatment of Parkinson’s Disease to Be Launched as CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules

August 8, 2024
Amneal Receives U.S. FDA Approval for Potassium Phosphates Injection IV Bags
Press Releases
Author

Amneal Receives U.S. FDA Approval for Potassium Phosphates Injection IV Bags

July 31, 2024
Amneal Pharmaceuticals | We’re Branching Out Into Premix Bags
Product Awareness
Author

Amneal Pharmaceuticals | We’re Branching Out Into Premix Bags

July 1, 2024
Amneal Pharmaceuticals | We’re Branching Out Into Premix Bags [Video]
Product Awareness
Author

Amneal Pharmaceuticals | We’re Branching Out Into Premix Bags [Video]

June 26, 2024
Must See Booths: Pharmacy Futures 2024
Must-See Exhibits & Booths
Author

Must See Booths: Pharmacy Futures 2024

June 8, 2024
Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose
Press Releases
Author

Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose

April 25, 2024
March Market Leaders: Pharmaceutical Manufacturers
Product Awareness
Author

March Market Leaders: Pharmaceutical Manufacturers

March 1, 2024
Amneal Launches Complex Generic Fluorometholone Ophthalmic Suspension
Press Releases
Author

Amneal Launches Complex Generic Fluorometholone Ophthalmic Suspension

January 11, 2024
Amneal Pharmaceuticals is Named a 2024 Pharmacy500 Company!
Announcements
Author

Amneal Pharmaceuticals is Named a 2024 Pharmacy500 Company!

January 1, 2024
Amneal Pharmaceuticals | Consistent Supply, Proven Quality and Reliable Service
Product Awareness
Author

Amneal Pharmaceuticals | Consistent Supply, Proven Quality and Reliable Service

December 13, 2023
Must See Booths: 2023 ASHP Midyear Clinical Meeting
Must-See Exhibits & Booths
Author

Must See Booths: 2023 ASHP Midyear Clinical Meeting

December 2, 2023
Amneal Receives U.S. FDA Approval for Calcium Gluconate Injection
Press Releases
Author

Amneal Receives U.S. FDA Approval for Calcium Gluconate Injection

September 13, 2023
Amneal Receives U.S. FDA Approval for Lisdexamfetamine Dimesylate
Press Releases
Author

Amneal Receives U.S. FDA Approval for Lisdexamfetamine Dimesylate

September 11, 2023
Amneal Receives 505(b)(2) NDA Approval from FDA for PEMRYDI RTU®, a Ready-to-Use Oncology Injectable
Press Releases
Author

Amneal Receives 505(b)(2) NDA Approval from FDA for PEMRYDI RTU®, a Ready-to-Use Oncology Injectable

June 14, 2023
Must See Booths: ASHP Summer Meetings & Exhibition 2023
Must-See Exhibits & Booths
Author

Must See Booths: ASHP Summer Meetings & Exhibition 2023

June 9, 2023
Amneal Launches Third Biosimilar with FYLNETRA™ (pegfilgrastim-pbbk) in the United States
Press Releases
Author

Amneal Launches Third Biosimilar with FYLNETRA™ (pegfilgrastim-pbbk) in the United States

May 17, 2023
March Market Leaders: Pharmaceutical Manufacturers
Product Awareness
Author

March Market Leaders: Pharmaceutical Manufacturers

March 1, 2023
Amneal Pharmaceuticals | Available When You Need Them Most … Multi-Source Injectable Products [VIDEO]
Product Awareness
Author

Amneal Pharmaceuticals | Available When You Need Them Most … Multi-Source Injectable Products [VIDEO]

January 9, 2023
Amneal Pharmaceuticals | Available When You Need Them Most … Multi-Source Injectable Products
Product Awareness
Author

Amneal Pharmaceuticals | Available When You Need Them Most … Multi-Source Injectable Products

December 6, 2022
Must See Booths: ASHP Midyear Clinical Meeting & Exhibition 2022
Must-See Exhibits & Booths
Author

Must See Booths: ASHP Midyear Clinical Meeting & Exhibition 2022

December 2, 2022
Amneal Receives Approval for Leuprolide Acetate
Press Releases
Author

Amneal Receives Approval for Leuprolide Acetate

November 3, 2022
Amneal Launches First Biosimilar with ALYMSYS® (bevacizumab-maly) in the United States
Press Releases
Author

Amneal Launches First Biosimilar with ALYMSYS® (bevacizumab-maly) in the United States

October 5, 2022
Must See Booths: NACDS Total Store Expo 2022
Must-See Exhibits & Booths
Author

Must See Booths: NACDS Total Store Expo 2022

August 27, 2022
Amneal launches 4 new Generic products, including Vasopressin single-dose
Press Releases
Author

Amneal launches 4 new Generic products, including Vasopressin single-dose

August 15, 2022
Because Consistent Supply is what you Demand — Amneal [VIDEO]
Product Awareness
Author

Because Consistent Supply is what you Demand — Amneal [VIDEO]

August 8, 2022
Amneal Launches Bexarotene Gel, 1%
Press Releases
Author

Amneal Launches Bexarotene Gel, 1%

June 1, 2022
TODAY'S POSTS

Connect with RXinsider

Stay informed on pharmacy supply chain news, market trends, and product releases by subscribing to RXinsider’s emails, newsletters, and publications. If building awareness with pharmacy management is part of your marketing strategy, consider advertising with RXinsider.

Subscribe
Advertise

RXinsider
1300 Division Road, Suite 103
West Warwick, RI 02893

The BUZZ / News

Publications

Marketplace

Multimedia Content

Market Intelligence

Career Center

Subscribe

Company

Subscribe
© 2025 RXinsider | All Rights Reserved.

SUBSCRIBE

Please enable JavaScript in your browser to complete this form.
Name
Subscription Choices
Checkboxes

Request information from Reimagining Sustainable Cold Chain Logistics with CCT EcoFlex™ Standard

Please enable JavaScript in your browser to complete this form.
Name
Address
Subscribe